Key facts
- This page summarizes David L. Lucchino's Form 4 filing for Korro Bio, Inc. (KRRO).
- 10 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Nov 2023, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Award
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Footnote F2
Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Footnote F3
Reflects shares of the Issuer's common stock received upon execution of a separation agreement effective November 3, 2023 resulting in vesting of performance RSUs granted April 11, 2022, as adjusted for the 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Footnote F4
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.
Footnote F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.575 to $37.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
Footnote F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.155 to $40.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
Footnote F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.45 to $42.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
Footnote F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.75 to $43.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
Footnote F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.87 to $44.175, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
Footnote F10
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.07 to $46.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.